Browsing bySubjectTyrosine kinase inhibitor

Jump to:
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 2 to 3 of 3

Issue DateTitleAuthor(s)Type
2022Safety and efficacy of nilotinib in adult patients with chronic myeloid leukemia: a post-marketing surveillance study in Korea성주명Article
2022The value measurement of emerging therapeutics in renal cell carcinoma: ASCO value framework and ESMO-MCBS배승진Article

BROWSE